Nazarov, A.Gardini, D.Baquié, M.Juillerat-Jeanneret, L.Serkova, T. P.Shevtsova, E. P.Scopelliti, R.Dyson, Paul Joseph2013-03-262013-03-262013-03-26201310.1039/c2dt31936ehttps://infoscience.epfl.ch/handle/20.500.14299/90573WOS:000313804200002Two hybrid compounds comprising an antimetastatic rutheniumarene fragment tethered to an indazole-3-carboxylic acid derivative that inhibits aerobic glycolysis in cancer cells have been prepared and evaluated in a variety of cancer cell lines, including highly relevant human glioblastoma cells, with an apparent synergistic action between the two components observed.text::journal::journal article::research article